Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7

specific

Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral me

35

Centers

0

Active Trials

Cancer Funding

Top Centers for Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7(35)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
151.4
2
NCI Comprehensive
51.4
3
NCI Comprehensive
51.4
4
NCI Comprehensive
51.4
551.4
6
NCI Comprehensive
51.4
7
NCI Comprehensive
51.4
851.4
951.4
10
NCI Comprehensive
51.4
1151.4
12
NCI Comprehensive
51.4
13
NCI Comprehensive
51.4
1451.4
1551.4
16
NCI Comprehensive
51.4
1751.4
1851.4
1951.4
20
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
51.4
2151.4
2251.4
2351.4
2451.4
25
NCI Comprehensive
51.4
2651.4
2751.4
2851.4
2951.4
3051.4
3151.4
3251.4
3351.4
34
BC CancerVancouver, BC
51.4
3551.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →